CFG
XLRN

Citizens Financial Group’s Acceleron Pharma XLRN Stock Holding History

Citizens Financial Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$95K – 1049
2020
Q2 		$95K Hold
1,000
– – 0.01% 370
2020
Q1 		$90K Buy
+1,000
New +$77.7K 0.01% 343
2019
Q2 		– Sell
-1,000
Closed -$47K – 869
2019
Q1 		$47K Buy
+1,000
New +$43.9K ﹤0.01% 364

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citizens Financial Group's XLRN Position: Q3 2020 in Review

Citizens Financial Group sold out of Acceleron Pharma (XLRN) in Q3 2020, closing a stake of 1,000 shares — an estimated $95K sold.

Citizens Financial Group first reported a position in XLRN in Q1 2019 and held it in 3 quarters. The position peaked at $95K in Q2 2020. 238 funds tracked by Wall St. Rank hold XLRN as of Q3 2020.

  • Citizens Financial Group reported no remaining Acceleron Pharma position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 1,000 Acceleron Pharma shares in Q3 2020, an estimated $95K.
  • Citizens Financial Group first reported a position in Acceleron Pharma in Q1 2019 and held it in 3 quarters.
  • Citizens Financial Group's Acceleron Pharma position peaked at $95K in Q2 2020.
  • 238 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.